Novavax, Inc. (Nasdaq: NVAX) today announced it will report its third quarter 2025 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, November 6, 2025. Details of the event and replay are as follows:
— Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.
— Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call.
— To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled start time.
About NovavaxNovavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M® adjuvant. The Company's growth strategy seeks to optimize its existing partnerships and expand access to its proven technology platform via research and development innovation, organic portfolio expansion in infectious disease and beyond, and forging new partnerships and collaborations with other companies. Please visit novavax.comand LinkedIn for more information.
Contacts:
InvestorsLuis Sanay, CFA240-268-2022ir@novavax.com
MediaYvonne Sprow844-264-8571media@novavax.com
https://mma.prnewswire.com/media/2343668/Novavax_High_Res_Logo.jpg
https://edge.prnewswire.com/c/img/favicon.png?sn=PH10710&sd=2025-10-30
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-report-third-quarter-2025-financial-results-on-november-6-2025-302599179.html
SOURCE Novavax, Inc.
https://rt.newswire.ca/rt.gif?NewsItemId=PH10710&Transmission_Id=202510300800PR_NEWS_USPR_____PH10710&DateId=20251030